Friday, January 05, 2018 10:15 PM ET
Insider Sales at MyoKardia (MYOK) are Significant and Extend the Selling Trend of Last Quarter
Two insiders — Kevin P Starr, 10% Owner and Director, and Rock Ventures, L.P. Third, 10% Owner — today, sold 1,632,652 shares of MyoKardia having a market value of approximately $68,571,547, as disclosed in form 4 documents filed with the SEC. In the past 90 days prior to this transaction there was one insider buy/sell transaction which resulted in the sale of 5,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 1,637,652 shares and have averaged 545,884 shares per transaction over this time period.
During the last 90 days, the number of insider buy/sell trades at MyoKardia is greater than the 279-company peer group average. Bio Therapeutic Drugs peer group saw 314 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for MyoKardia insiders was also higher. Within the peer group there were 42,508,637 shares purchased and 38,969,339 shares sold with company insiders purchasing 17,435 shares on average.
The data used in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* Kevin P Starr, 10% Owner and Director, sold 816,326 shares
* Rock Ventures, L.P. Third, 10% Owner, sold 816,326 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.